is...(Busy)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
However, I do like Jim Crammers Video's at the CNBC web site, giving real insight on how to read a chart!
good info. "Old school stuff!" IMO
Thanks, Mr. Crammer.....
The (AWSM) chart helped me with my entry point, for sure!
Boooo yaaa!
Cheers!
Sincerely,
Best,
raptor
Good luck to all!
TY,
Well said!
Cheers!
Good luck to all!
I use to do the exact opposite of Jim Cramer's picks/advise, it worked, I made a lot of money, back in the day!
He may be getting better these days, I don't know, I don't watch him any more.
Cheers!
Good luck to all!
Moar!
">" />
Cool Holdings Provides Corporate Update
Simply Mac Acquisition and Future Plans
PR Newswire
MIAMI, Dec. 2, 2019
MIAMI, Dec. 2, 2019 /PRNewswire/ -- Cool Holdings, Inc. (OTCQB: AWSM) (the "Company" or "Cool Holdings"), the parent company of Simply Mac, Inc., the largest Apple Premier Partner in the U.S., provided a corporate update today regarding its recent accomplishments and its future plans. Having recently completed the acquisition of Simply Mac, the Company has a target to achieve positive EBITDA and restructure its balance sheet in 2020.
Reinier Voigt, President and Chief Executive Officer of Cool Holdings, commented: "We believe that the key to getting our Company profitable was provided to us on September 25, 2019 when we completed the acquisition of Simply Mac. Owning the largest Apple Premier Partner in the U.S. provides us with a superb platform upon which to build and transform our Company. Not unexpectedly, when Interbrand, the global brand consulting firm, recently published its 2019 ranking of top brands, Apple ranked #1 for the 7(th) consecutive year. Simply Mac has been a Premier Partner since 2006 and we continue to believe in the longevity of Apple as a company and its constant innovation and roadmap of future products."
Continuing, Mr. Voigt noted: "With this 'key' now in our possession, we still have a lot of work to do to unlock Simply Mac's potential. Some of that work includes continual improvements in product purchasing, especially for third party accessories, and avoiding the pitfalls of having excess inventories which hampers working capital, margins and administrative management. We will endeavor to properly stock our stores with inventory at the peak seasonal sales periods. Improving our inventory turns and cash-to-cash cycle will be important to achieving profitability, especially in a constrained capital environment. Simply Mac is one of the top providers of service for Apple products in the U.S. and we need to leverage that. Service is a category that generates our highest gross margins and we have plans to open smaller footprint stores that focus almost entirely on this offering. In fiscal 2018, Simply Mac reported $90.2 million in sales. With that level of sales, for every 1% improvement in gross margin and/or operating profit margin we are able to achieve, we could add approximately $900,000 to the bottom line. Additionally, we will work with our current debt holders to deleverage our balance sheet and add more permanent capital to our Company, as well as seek new equity for growth."
The Executive Team
Cool Holdings is led by Reinier Voigt, who was appointed in June 2019 as a Director and the Company's President and Chief Executive Officer. Prior to that, he served as Chief Operating Officer since December 2016. From May 2015 until August 2016, Mr. Voigt was President and Chief Operating Officer of TEReI International, a merchant bank focused on debt and equity opportunities in the small to mid-cap markets in North and South America, and from September 2006 until April 2015 he was the Chief Operation Officer of Facey Telecom. Mr. Voigt has more than twenty years of experience in business operations which includes a focus on profit and loss optimization, strategic planning, finance and financial reporting.
The Company's Chief Financial Officer is Vernon A. LoForti, who was appointed to that position in June 2019. Prior to that, he served the Company as its Vice President and Secretary, beginning after the merger with Cooltech Holding in March 2018. Mr. LoForti previously served as the Chief Financial Officer of InfoSonics from July 2010 through the date of the merger. Prior to InfoSonics, Mr. LoForti served as CEO of Overland Storage, Inc., a global supplier of data protection appliances, where he worked for 14 years and led the company's initial public offering as its CFO. Beginning his career in public accounting with Price Waterhouse in Los Angeles, Mr. LoForti has thirty-five years of experience as a financial executive with U.S. publicly-held companies.
Key to the management team of Simply Mac is Howard Young, Vice President of Sales and Operations. Mr. Young has over 19 years of sales and operations management experience, and is continually focused on revenue and margin generation, cost savings and process improvements, while ensuring Simply Mac maintains best in class customer service and strong relationships with Apple. Prior to joining the company in 2011, Mr. Young worked for almost 4 years for Apple as a store leader, and prior to that was in management positions at Best Buy and Pottery Barn.
Store Base
After the opening on November 16, 2019 of the newest Simply Mac store in Louisville, Kentucky, Cool Holdings currently operates a total of 58 Apple retail stores under its 2 brands: Simply Mac and OneClick. Located primarily in smaller cities close to a university where Apple has no presence, Simply Mac is an important provider of Apple authorized service in the U.S. There are 42 Simply Mac stores located in 18 states in the U.S. as follows:
Alabama 1Indiana 2Tennessee 4
Arkansas 1Kentucky 1Texas 4
Colorado 1Missouri 1Utah 5
Georgia 8Montana 2Virginia 1
Idaho 1Ohio 1Washington 1
Illinois 1Oregon 6Wyoming 1
The 16 OneClick stores are located as follows: 7 in the Dominican Republic, 6 in Argentina and 3 in Florida.
Immediate Store-Level Focus
Cool Holdings immediate focus will be on the following areas of store operations and performance:
-- Florida OneClick Store Rebranding. Beginning in 2020, the Company plans
to rebrand the 3 OneClick stores in Florida as Simply Mac stores in order
to consolidate all U.S. locations under the strength of the Simply Mac
brand name.
-- Capitalize on the synergies between OneClick and Simply Mac. The Company
has already begun the process of cross pollinating the strengths of the
two brands. Simply Mac stores generate superior margins by selling
Certified Preowned ("CPO") Apple products and their own brand of extended
warranty called "Simple Care." The Company's OneClick stores are now
beginning to offer these products. One Click did a better job at product
management of third-party accessories in terms of a better portfolio of
products and better pricing as it took advantage of direct relationships
with manufacturers. This strength is now being implemented at Simply Mac,
who previously relied primarily on purchasing accessories only from its
distribution suppliers.
-- Maximize Simply Mac's strength in repair service. Simply Mac is a market
leader in warranty repair and service of Apple products. It intends to
identify markets and locations where it can open smaller footprint
locations focused almost entirely on service. Such locations would have
lower labor, operating and occupancy costs, as well as only minimal
inventory or product display levels. This would translate into
significantly higher operating profit margins.
-- Examine SKUs sold in each store. The 80/20 rule is usually in effect in
that 20% of retail SKUs generate 80% of gross profit. This is especially
true in third party accessories. The Company is focusing on buying
smarter and managing inventory better to avoid excess inventory and
write-downs, increase inventory turns and minimizing working capital
needs. The Company's business is very seasonal with peak sales periods
occurring around holidays periods throughout the year, consistent with
consumer electronic buying patterns. Consequently, the Company is
working to ensure its stores are properly stocked during those periods to
maximize ROI.
-- Strive to provide superior customer service. Adopting Simply Mac's
founding vision, Cool Holdings will strive to be one of America's Premier
Technology Retailers. Superior customer service is critical to making
this a reality, and it is a metric that Apple monitors closely. The
Company will strive to continue to hire the best people, train them
properly and provide them with the right incentives to be successful.
Then, as stated in our Simply Mac pledge, "we must take great care of our
customers, or someone else will."
-- Evaluate under-performing stores to improve overall profitability. The
Company monitors the performance of each and every retail store on a
daily basis against the prior year and budget. Management works to
promptly identify underperforming stores, isolate reasons for
underperformance, assess management and staffing, find ways to increase
sales and/or reduce operating costs and consider relocation where
necessary.
Partnership with Torque Esports
On October 29, 2019, Cool Holdings signed a 3-year agreement with Torque Esports Corp., formerly Millennial Esports Corp. (TSX VENTURE: GAME, OTCQB: MLLLF) ("Torque"). This partnership is designed to drive more traffic to all the Simply Mac stores. Under the agreement, Simply Mac is now the named sponsor and sole and exclusive supplier of Apple products for "America's Fastest Gamer" events produced by Ideas & Cars. Commenting on the partnership, Darren Cox, Torque President and CEO, stated: "We were thrilled to be working with Simply Mac to not only showcase their brand to the millions of television viewers who watch the documentary series of World's Fastest Gamer around the world, but also to use the incredible tools from Apple they provide to us to actually create the series content. At Torque, we're not only using Apple MacBook Pros and iMacs to create the documentary series, but we also used the iPhone 11 Pro to shoot our social media content produced throughout the #CaliforniaDreamin finals tour."
Recapitalization Efforts
(MORE TO FOLLOW) Dow Jones Newswires
December 02, 2019 08:00 ET (13:00 GMT)
The one day chart, today, looks like a Christmas tree to me!
Cheers!
Good luck to all!
Hell ya!!!!
CYTR has great news out today!
Up 13.46% today
http://www.cytrx.com/
LOS ANGELES, Dec. 19, 2019 /PRNewswire/ -- CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company, today highlighted Orphazyme A/S received FDA Breakthrough Therapy Designation for arimoclomol for NPC. Breakthrough Therapy Designation is a program intended to expedite the development and review of drugs to treat serious or life-threatening diseases in cases where preliminary clinical evidence shows that the drug may provide substantial improvements over available therapy.
(PRNewsfoto/CytRx Corporation)
(PRNewsfoto/CytRx Corporation)
Orphazyme also announced they have received Fast Track status from the FDA for arimoclomol in sIBM. This is their second Fast Track Designation for arimoclomol, which CytRx licensed to Orphazyme in 2011. Receiving the designation on multiple occasions shows the significant potential of arimoclomol in orphan diseases.
Arimoclomol has been shown to have a clinically meaningful effect on disease progression in NPC that is further supported by a biomarker effect indicating an effect on the biological underpinnings of the disease and a favorable safety and tolerability profile. Orphazyme is committed to bringing this product to patients as soon as possible. Breakthrough Therapy Designation is designed to expedite the development and review of products for serious diseases with the direct involvement of senior staff at Orphazyme working closely with the FDA to further advance arimoclomol. Preparations for filing in the U.S. are underway and the company has indicated it is on track to submit a New Drug Application in H1 2020.
"It is very gratifying to see the advances being made with arimoclomol, which CytRx developed and licensed to Orphazyme. We expect that patients who are diagnosed with these serious orphan diseases will soon have a treatment with arimoclomol," said Eric Curtis, President and Chief Operating Officer of CytRx.
CytRx has an agreement with Orphazyme that will pay CytRx up to $120 million in milestones, plus single and double-digit royalties for arimoclomol.
ImmunityBio, Inc. ("ImmunityBio") announced Results of its Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy with Durable, Complete Response Data and 78% Disease Control in Refractory Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium. This immunotherapy includes CytRx's aldoxorubicin as part of its innovative chemoradiation therapy.
"We are very pleased to see aldoxorubicin being utilized in this promising protocol for triple negative breast cancer patients who so desperately need advances in therapy to fight their disease," said Eric Curtis, President and Chief Operating Officer of CytRx.
CytRx out-licensed global development, manufacturing, and commercialization rights for aldoxorubicin to ImmunityBio in July 2017. CytRx has an agreement with ImmunityBio that will pay CytRx up to $343 million in milestones, plus single and double-digit royalties for aldoxorubicin.
Cheers
Good luck to all!
CYTR has great news out today!
Up 13.46% today
http://www.cytrx.com/
LOS ANGELES, Dec. 19, 2019 /PRNewswire/ -- CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company, today highlighted Orphazyme A/S received FDA Breakthrough Therapy Designation for arimoclomol for NPC. Breakthrough Therapy Designation is a program intended to expedite the development and review of drugs to treat serious or life-threatening diseases in cases where preliminary clinical evidence shows that the drug may provide substantial improvements over available therapy.
(PRNewsfoto/CytRx Corporation)
(PRNewsfoto/CytRx Corporation)
Orphazyme also announced they have received Fast Track status from the FDA for arimoclomol in sIBM. This is their second Fast Track Designation for arimoclomol, which CytRx licensed to Orphazyme in 2011. Receiving the designation on multiple occasions shows the significant potential of arimoclomol in orphan diseases.
Arimoclomol has been shown to have a clinically meaningful effect on disease progression in NPC that is further supported by a biomarker effect indicating an effect on the biological underpinnings of the disease and a favorable safety and tolerability profile. Orphazyme is committed to bringing this product to patients as soon as possible. Breakthrough Therapy Designation is designed to expedite the development and review of products for serious diseases with the direct involvement of senior staff at Orphazyme working closely with the FDA to further advance arimoclomol. Preparations for filing in the U.S. are underway and the company has indicated it is on track to submit a New Drug Application in H1 2020.
"It is very gratifying to see the advances being made with arimoclomol, which CytRx developed and licensed to Orphazyme. We expect that patients who are diagnosed with these serious orphan diseases will soon have a treatment with arimoclomol," said Eric Curtis, President and Chief Operating Officer of CytRx.
CytRx has an agreement with Orphazyme that will pay CytRx up to $120 million in milestones, plus single and double-digit royalties for arimoclomol.
ImmunityBio, Inc. ("ImmunityBio") announced Results of its Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy with Durable, Complete Response Data and 78% Disease Control in Refractory Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium. This immunotherapy includes CytRx's aldoxorubicin as part of its innovative chemoradiation therapy.
"We are very pleased to see aldoxorubicin being utilized in this promising protocol for triple negative breast cancer patients who so desperately need advances in therapy to fight their disease," said Eric Curtis, President and Chief Operating Officer of CytRx.
CytRx out-licensed global development, manufacturing, and commercialization rights for aldoxorubicin to ImmunityBio in July 2017. CytRx has an agreement with ImmunityBio that will pay CytRx up to $343 million in milestones, plus single and double-digit royalties for aldoxorubicin.
Cheers
Good luck to all!
CYTR has great news out today!
Up 13.46% today
http://www.cytrx.com/
LOS ANGELES, Dec. 19, 2019 /PRNewswire/ -- CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company, today highlighted Orphazyme A/S received FDA Breakthrough Therapy Designation for arimoclomol for NPC. Breakthrough Therapy Designation is a program intended to expedite the development and review of drugs to treat serious or life-threatening diseases in cases where preliminary clinical evidence shows that the drug may provide substantial improvements over available therapy.
(PRNewsfoto/CytRx Corporation)
(PRNewsfoto/CytRx Corporation)
Orphazyme also announced they have received Fast Track status from the FDA for arimoclomol in sIBM. This is their second Fast Track Designation for arimoclomol, which CytRx licensed to Orphazyme in 2011. Receiving the designation on multiple occasions shows the significant potential of arimoclomol in orphan diseases.
Arimoclomol has been shown to have a clinically meaningful effect on disease progression in NPC that is further supported by a biomarker effect indicating an effect on the biological underpinnings of the disease and a favorable safety and tolerability profile. Orphazyme is committed to bringing this product to patients as soon as possible. Breakthrough Therapy Designation is designed to expedite the development and review of products for serious diseases with the direct involvement of senior staff at Orphazyme working closely with the FDA to further advance arimoclomol. Preparations for filing in the U.S. are underway and the company has indicated it is on track to submit a New Drug Application in H1 2020.
"It is very gratifying to see the advances being made with arimoclomol, which CytRx developed and licensed to Orphazyme. We expect that patients who are diagnosed with these serious orphan diseases will soon have a treatment with arimoclomol," said Eric Curtis, President and Chief Operating Officer of CytRx.
CytRx has an agreement with Orphazyme that will pay CytRx up to $120 million in milestones, plus single and double-digit royalties for arimoclomol.
ImmunityBio, Inc. ("ImmunityBio") announced Results of its Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy with Durable, Complete Response Data and 78% Disease Control in Refractory Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium. This immunotherapy includes CytRx's aldoxorubicin as part of its innovative chemoradiation therapy.
"We are very pleased to see aldoxorubicin being utilized in this promising protocol for triple negative breast cancer patients who so desperately need advances in therapy to fight their disease," said Eric Curtis, President and Chief Operating Officer of CytRx.
CytRx out-licensed global development, manufacturing, and commercialization rights for aldoxorubicin to ImmunityBio in July 2017. CytRx has an agreement with ImmunityBio that will pay CytRx up to $343 million in milestones, plus single and double-digit royalties for aldoxorubicin.
Wow! Great news out today.
Good volume
Cheers!
Good luck to all
I like the web site!
https://us.sunpower.com/
So, what is the sentament/price target in this room?
Cheers
Good luck to all!
lol - 404 error
Try again...
http://www.coolholdings.com/corp/
I like the website!
Very user friendly, easy to get to the 2019 Proxy to view in PDF format.
[http://www.coolholdings.com/corp/]
Cheers!
Good luck to all
jonsmile
My sentiment exactly when I looked at this again a couple days ago after 8 years in my watch list.
I am reading in the news release Dec 2nd, the new President starting in June 2019 is kind of saying, work in progress.
Mr. Voigt states "the Company has a target to achieve positive EBITDA and restructure its balance sheet in 2020."
See article below:
like others in this room, I personally am adding what I can now and I am holding ~ long ~
I just wish 2020 will get here quicker!
If this isn't the bottom, God help us all, sure looks and seems like the bottom.
JMO
Good luck to all
Cheers
MIAMI, Dec. 2, 2019 /PRNewswire/ -- Cool Holdings, Inc. (OTCQB: AWSM) (the "Company" or "Cool Holdings"), the parent company of Simply Mac, Inc., the largest Apple Premier Partner in the U.S., provided a corporate update today regarding its recent accomplishments and its future plans. Having recently completed the acquisition of Simply Mac, the Company has a target to achieve positive EBITDA and restructure its balance sheet in 2020.
I had this stock in my watch list in 2011.
Blast from the past....lol
Wow, looks like the new CEO has been very busy.
Store opened in Ky., Corporate updates, new filings.
Odd, the volume is so low.
Could be a forgotten diamond in the rough.
Looking forward to watching the progress in 2020.
Good luck to all!!
Cheers
I had this stock in my watch list in 2011.
Blast from the past....lol
Wow, looks like the new CEO has been very busy.
Store opened in Ky., Corporate updates, new filings.
Odd, the volume is so low.
Could be a forgotten diamond in the rough.
Looking forward to watching the progress in 2020.
Good luck to all!!
Cheers
Open down 3% then gap up
Looking for $25-$28
Jmo
1,000,000 shares dumped in 10 trades at 9:36 a.m.
https://www.otcmarkets.com/stock/RMHB/quote#trade-data
Nutrition Labeling and Education Act of 1990.
https://en.m.wikipedia.org/wiki/Nutrition_Labeling_and_Education_Act_of_1990
Does the FDA regulate energy drinks?
https://www.energydrinkslawsuit.com/fda-regulate-energy-drinks/
Good luck to all
Cheers!
I want the Eagle spirit water as well!
Found on Amazon
https://www.amazon.com/gp/aw/d/B06XD212XB/ref=mp_s_a_1_1_a_it?ie=UTF8&qid=1548895006&sr=8-1&keywords=eagle+spirit+water&dpPl=1&dpID=51iFIX6gVLL&ref=plSrch
24 bottles for $36 dollars!
I like the alkaline water, coming out of a good spring in Okla.
Well, I am going to order some of the products off Amazon and try them.
I found the prices on the Hempd product's are very competitive.
Like this: 24 cans for $35
Found on Amazon
https://www.amazon.com/gp/aw/s/ref=is_s?k=hempd
Good luck to all
Cheers!
I am patient, however, I do my DD!
I use to live in Dallas, back in the 80's so I do know where the corperate office is. Impressive.
Funny, I put the corperate address in Google earth and clicked on the street view, picture probably taken by Google in 2015, nice office. Then I walked down the parking lot and found the old van in the parking lot, nice graphics, however, I do like the new van better.
Dallas, Texas
RMHB corperate office.
The map opens looking at the pavement, a mouse or finger on a smart phone allows you to look and walk around to find the cool Van.
https://goo.gl/maps/DwGpNPgv9P52
Have not heard back from my info request yet, maybe the information I am looking for will just show up in press releases and new podcasts.
Good luck to all,
Cheers!
Some believe, and I am one of them, (IMO) when the Clinton admin. repealed the Glass-Steagul act, that was the root cause of the sub-prime debacle!
In November 1999, US President Bill Clinton signed into law the Gramm–Leach–Bliley Act, which repealed provisions of the Glass-Steagall Act that prohibit a bank holding company from owning other financial companies. The repeal effectively removed the separation that previously existed between Wall Street investment banks and depository banks, providing a government stamp of approval for a universal risk-taking banking model. Investment banks such as Lehman would now be thrust into direct competition with commercial banks.[117] Most analysts say that this repeal directly contributed to the severity of the Financial crisis of 2007–2010.
https://en.m.wikipedia.org/wiki/Financial_crisis_of_2007–2008
I suspect the Fed. meeting is effecting everything...
The proof is in the pudding, Thursday morn! IMO
Fresh details on the central bank’s plan for its balance-sheet reduction will also draw scrutiny after minutes from the December meeting showed it was open to dialing back the rate at which Treasurys and government-sponsored mortgage bonds rolled off its more than $4+ trillion asset portfolio.
https://www.google.com/amp/s/www.marketwatch.com/amp/story/guid/267B0FFA-23BE-11E9-B0BC-6FDC8FBAB48B
I am checking transparity.
I called the CFO today, good sign, he has a voice mail.
Then, I emailed them from their corperate web site, let them know I am a share holder and have some questions about the unusually high O/S and asked what the plan is for 2019.
If, and when I get a response I will disseminate the info to the board.
Good luck to all
I concur with your thinking, add more when it dips.
I am curious to see what the Feds. say today.
I have to say, RMHB is a catchy name, kind of like having a good jingle! Would be kind of cool idf they made comercials with John Denver's song playing in the background, just a thought.....
Good luck to all
lol, maybe it's not funny, I just found this. Wasn't it the past CEO that pushed all the paper?, and, is getting sued?
Welch serms to be trying to stear the boat more true North JMO, however, time will tell.
I have a small investment here but a large block, just incase he getts into high cotten one day.
Good luck to all
News: Rocky Mountain High Brands Announces SEC Form 8-K Filing for Co-Packing Agreement and Second Amendment to Master Manufacturing Agreement with CBD Alimentos SA de CV
https://globenewswire.com/news-release/2019/01/25/1705571/0/en/Rocky-Mountain-High-Brands-Announces-SEC-Form-8-K-Filing-for-Co-Packing-Agreement-and-Second-Amendment-to-Master-Manufacturing-Agreement-with-CBD-Alimentos-SA-de-CV.html
Whatzzzzzzzzzzzzzzz up?
Wazzzzzzzzzzzz up?
Well, I certainly like the chart!
Thank you for the info, Breez!
I suspected that the protocol had/has not changed.
I may add to my position again.
I am not trying to "be like Buffet," However, I believe it sure doesn't hurt to follow a good trusted leader, just my honest opinion sir/mam, what ever the case may be.
Thank you for your due diligence.
Good fortune to all,
Cheers!
QQ
-
I got in at $4, the question is, Is the Frost team still adding to the position?
I have been busy and looked away from this investment for some time.
Regardless of my lack of attention to the madder, I still am a believer in the Frost business plan for the future.
Good fortune to all!
Cheers!
QQ
-
BLUE HORSE LIKES (ADST)
BLAST FROM THE_PAST... . ...
http://finance.yahoo.com/echarts?s=ADST+Interactive#symbol=ADST;range=5d
AdStar Inc. (ADST)
-Other OTC Follow
0.0080 Up 0.0020(33.33%) Jun 16, 3:45PM EDT
Pre-Market : NaN
Any thoughts?
Just speculation
QQ
-
Cheers